Stockguru.com: Stocks to Watch for November 6, 2008 - CSUH, MCTI, IMUC, DSBO, and NEOP

Nov 06, 2008 (M2 PRESSWIRE via COMTEX) -- NEOP | Quote | Chart | News | PowerRating -- Our Stocks to Watch today include Celsius Holdings, Inc. (OTCBB: CSUH), Micro Component Technology, Inc. (OTCBB: MCTI), ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), Disaboom (OTCBB: DSBO), and Neoprobe Corporation (OTCBB: NEOP)

Visit: http://www.stockguru.com to register for our daily Stocks to Watch and Trade Alerts.

Celsius Holdings, Inc. (OTCBB:CSUH) Shares traded down 3.64% at $0.05

Celsius Holdings, Inc., through its subsidiaries, Celsius, Inc. and Celsius Netshipments, Inc., engages in the production, distribution, and marketing of functional beverages in the United States. The company offers Celsius, a calorie burning soda, which is available in cola, ginger ale, lemon/lime, orange, and wild berry flavors. It sells its products through grocery, drug, convenience, club, and mass channels; health and fitness channels, including health clubs, spas, gyms, and similar locations; and vending and food service channels. Celsius Holdings also sells its products through the Internet. The company was founded in 2004 and is based in Delray Beach, Florida.

CSUH News Yesterday, Celsius Holdings reported net sales today for the three-month period ending September 30, 2008 of $435,000 -- a decrease as compared to $508,000 for the three-month period ending September 30, 2007. The company also reported a net loss of $1.8 million (or $0.01 per basic and diluted share) for the three months ending September 30, 2008. This compares with net loss of $784,000 (or $0.01 per basic and diluted share) for the three months ending September 30, 2007.

Micro Component Technology, Inc. (OTCBB:MCTI) Shares traded down 20% at $0.0020

Micro Component Technology, Inc. engages in the design, manufacture, market, and service of automated test handling equipment for the semiconductor industry. The company?s handlers are designed to handle semiconductor or integrated circuit device packages. It offers equipment automation solutions for the test, laser mark, and mark inspect processes for the back-end of the semiconductor manufacturing process. The company?s solutions include its series of integrated Smart Solutions, automated test handlers, factory automation software, and equipment integration services. Micro Component Technology markets its products primarily to semiconductor manufacturers, and third party test and assembly companies through its own sales force, and independent sales representatives and distributors in the United States, Asia, and Europe. The company was founded in 1972 and is headquartered in St. Paul, Minnesota.

MCTI News Yesterday, Micro Component Technology reported results for its third quarter ended September 27, 2008. Net sales for the third quarter of 2008, at $2.3 million, decreased 36% over the third quarter of 2007. The net loss was $2.2 million or $0.06 per share in the third quarter of 2008, compared to a net loss of $390,000 in the third quarter of 2007.

Neoprobe Corporation (OTCBB:NEOP) Shares traded down 3.17% at $0.61

Neoprobe Corporation, a biomedical company, develops and commercializes surgical and diagnostic products. The company offers gamma detection device systems that consist of hand-held detector probes and a control unit. Its products primarily include neo2000 Gamma Detection System, which is used in the surgical procedure, Sentinel Lymph Node Biopsy, or in the diagnosis and treatment of cancer, such as melanoma and breast cancer; and Quantix products that employ a proprietary technology for measurement of blood flow volume, velocity, and various other hemodynamic parameters, which permit the real-time assessment of conduit hemodynamic status. The company also holds developmental and/or intellectual property rights related to two drugs that might be used in connection with gamma detection devices in cancer surgeries. Its drugs under development include Lymphoseek, which determines the spread of solid tumor cancers; and RIGScan CR that enables surgeons to locate cancerous tissue during colorectal cancer surgeries. The company was founded in 1983 and is based in Dublin, Ohio.

NEOP News Yesterday, Neoprobe announced consolidated results for the third quarter of 2008 and for the nine-month period ended September 30, 2008. For the third quarter of 2008, Neoprobe reported a net loss of $1.9 million or $0.03 per share compared to a net loss of $942,000 or $0.01 per share for the third quarter in 2007. For the nine months ended September 30, 2008, Neoprobe reported a net loss of $3.9 million or $0.06 per share compared to a net loss of $3.2 million or $0.05 per share for the same period in 2007. Neoprobe's loss from operations for the third quarter of 2008 was $1.5 million compared to $90,000 for the third quarter of 2007. Neoprobe's loss from operations for the nine-month period ended September 30, 2008 was $2.3 million compared to $1.5 million for the same period of 2007.

Disaboom (OTCBB:DSBO) Shares traded up 50% at %0.18

Disaboom, Inc. engages in developing, operating, and marketing an interactive online community for people with disabilities or functional limitations. It offers Disaboom.com, an online community that provides medical information, healthcare content about a particular condition or diagnosis, and a range of topics and issues related to disability or functional limitation. The company?s Website comprises content, community, and microsites. It also serves families and friends, caregivers, recreation and rehabilitation providers, and employers of people with disabilities or functional limitations. The company was founded in 2006 and is headquartered in Denver, Colorado.

DSBO News Yesterday , Disaboom announced that John Walpuck, Disaboom's President and CFO, has been appointed CEO, in addition to his existing duties. "We're very excited that John will be stepping into this important role for Disaboom," notes J.W. Roth, co-founder, Chairman, and formerly the CEO. "This will finally allow me to focus on presenting the Disaboom story to the investment community, and explore various alternatives to increase shareholder value - while John expands his strategic as well as his day-to-day leadership role with the company."

Lyris, Inc., (OTCBB:LYRI) Shares traded up 12.50% at $0.45

Lyris, Inc., through its wholly owned subsidiaries, provides marketing technology solutions in the United States. The company offers Lyris HQ, an on demand Web-based marketing platform that brings together a suite of marketing technologies. Its email marketing software that provide clients with tools to create, deliver, and manage email marketing programs, newsletters, discussion groups, and other digital communications. The company?s email marketing software includes Lyris ListManager that provides email marketing engine to manage and execute campaigns; EmailLabs, a hosted email marketing software, which manages email campaigns and communications; and EmailAdvisor, a monitoring tool that helps facilitate the delivery of legitimate email. Lyris?s Web analytics software enables customers to track and report on the activity of visitors to a Web site or landing page. Its Web content management software includes Lyris? HotBanana to manage content across Web properties comprising corporate Web sites, intranets, extranets, landing pages, and micro marketing sites, as well as provides professional services for the Hot Banana offering, including creative design, content creation, and other Web site development services. The company?s solutions are available as licensed software that is installed on a client?s computers, and hosted solutions that clients access through the Internet and pay for on a subscription basis. Its customers include small and middle-market companies, as well as marketing and advertising agencies, government entities, and universities.

LYRI News Yesterday, Lyris reported results for the first quarter of fiscal 2009. For the quarter ended September 30, 2008, Lyris reported revenues of $11.0 million, compared with revenues of $10.7 million in the first quarter of fiscal 2008. The revenue breakout for the quarter included subscription software, 74 percent; licensed software, 10 percent; support and maintenance, 13 percent; and professional services, three percent. On a GAAP basis, the company reported a net loss of $1.1 million, or $0.01 per share. This compares with a net loss of $24,000, or $0.00 per share, in the same period a year ago. On a non-GAAP basis, Lyris reported a net loss of $196,000, or $0.00 per share, versus non-GAAP net income of $1.2 million, or $0.01 per diluted share, in the first quarter of fiscal 2008. Material exclusions from the non-GAAP results exclude amortization of intangibles of $868,000, and $1.0 million and stock-based compensation expense of $34,000 and $117,000 in the first quarters of 2009 and 2008, respectively.

ImmunoCellular Therapeutics, Ltd. (OTCBB:IMUC) Shares traded down 2.50% at $0.39

ImmunoCellular Therapeutics, Ltd. focuses on the development and commercialization of therapeutics to fight cancer using the immune system. The company?s product candidate portfolio includes cellular immunotherapies targeting cancer antigens and cancer stem cell antigens, and monoclonal antibodies to diagnose and treat various cancers. Its lead product candidate is a dendritic cell based vaccine, which is in a Phase I clinical trial to treat glioblastoma multiforme, a type of brain tumors. ImmunoCellular Therapeutics has a research agreement with Antitope, Ltd. for the humanization of IMUC's monoclonal antibodies. The company is based in Woodland Hills, California.

IMUC News Yesterday, ImmunoCellular Therapeutics announced that the company's president and chief executive officer, Manish Singh, Ph.D., will make a company presentation at the Rodman & Renshaw 10th Annual Healthcare Conference. The presentation will be webcast and will occur at 4:55 p.m. EST on Tuesday, November 11, 2008 at the New York Palace Hotel in New York City. The presentations will be audio webcast live and available for replay from IMUC's website, www.imuc.com.

About StockGuru.com:

StockGuru.com is an investment information web site for smallcap and over-the-counter bulletin board stocks. StockGuru features daily email alerts to members, company profiles, audio interviews of CEO's or other key executives, and company news. Company and financial reports are authored by business analysts. To join our email alert list, please visit: http://www.stockguru.com/index.php?option=com_content&view=article&id=31&Itemid=5

About ShareholderVision.com:

Occasionally companies mentioned are also featured at ShareholderVision.com. This innovative web site featuring company videos of corporate executives and key personnel. All videos are shot in high-definition format and are edited for content purposes.

To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031, or you email us at email: john@stockguru.com and we will gladly send you more information on featuring your company with StockGuru.com

Stockguru.com ("SG") provides its members with the latest news, press releases, and research reports for all the companies highlighted on the site. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.Stockguru.com or mentioned herein.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements.

CONTACT: John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com WWW: http://www.Stockguru.com

M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index